<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:15:08Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6375664" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6375664</identifier>
        <datestamp>2019-03-01</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6375664</article-id>
              <article-id pub-id-type="pmcid">PMC6375664</article-id>
              <article-id pub-id-type="pmc-uid">6375664</article-id>
              <article-id pub-id-type="pmid">30763347</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0210884</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-18-25281</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Cell biology</subject>
                    <subj-group>
                      <subject>Chromosome biology</subject>
                      <subj-group>
                        <subject>Chromatin</subject>
                        <subj-group>
                          <subject>Chromatin modification</subject>
                          <subj-group>
                            <subject>DNA methylation</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Epigenetics</subject>
                      <subj-group>
                        <subject>Chromatin</subject>
                        <subj-group>
                          <subject>Chromatin modification</subject>
                          <subj-group>
                            <subject>DNA methylation</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Gene expression</subject>
                      <subj-group>
                        <subject>Chromatin</subject>
                        <subj-group>
                          <subject>Chromatin modification</subject>
                          <subj-group>
                            <subject>DNA methylation</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>DNA</subject>
                      <subj-group>
                        <subject>DNA modification</subject>
                        <subj-group>
                          <subject>DNA methylation</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Nucleic acids</subject>
                      <subj-group>
                        <subject>DNA</subject>
                        <subj-group>
                          <subject>DNA modification</subject>
                          <subj-group>
                            <subject>DNA methylation</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Epigenetics</subject>
                      <subj-group>
                        <subject>DNA modification</subject>
                        <subj-group>
                          <subject>DNA methylation</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Gene expression</subject>
                      <subj-group>
                        <subject>DNA modification</subject>
                        <subj-group>
                          <subject>DNA methylation</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Oncology</subject>
                    <subj-group>
                      <subject>Cancers and Neoplasms</subject>
                      <subj-group>
                        <subject>Breast Tumors</subject>
                        <subj-group>
                          <subject>Breast Cancer</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Endocrinology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Menstrual Cycle</subject>
                        <subj-group>
                          <subject>Menarche</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Menstrual Cycle</subject>
                        <subj-group>
                          <subject>Menarche</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Menstrual Cycle</subject>
                        <subj-group>
                          <subject>Menarche</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Reproductive Physiology</subject>
                      <subj-group>
                        <subject>Menstrual Cycle</subject>
                        <subj-group>
                          <subject>Menarche</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Reproductive Physiology</subject>
                      <subj-group>
                        <subject>Menstrual Cycle</subject>
                        <subj-group>
                          <subject>Menarche</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Chemistry</subject>
                    <subj-group>
                      <subject>Chemical Reactions</subject>
                      <subj-group>
                        <subject>Methylation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Endocrinology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Lactation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Lactation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Endocrine Physiology</subject>
                      <subj-group>
                        <subject>Lactation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Reproductive Physiology</subject>
                      <subj-group>
                        <subject>Lactation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Reproductive Physiology</subject>
                      <subj-group>
                        <subject>Lactation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Diagnostic Medicine</subject>
                    <subj-group>
                      <subject>Cancer Detection and Diagnosis</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Oncology</subject>
                    <subj-group>
                      <subject>Cancer Detection and Diagnosis</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Epigenetics</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Oncology</subject>
                    <subj-group>
                      <subject>Carcinogenesis</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Reproductive characteristics modify the association between global DNA methylation and breast cancer risk in a population-based sample of women</article-title>
                <alt-title alt-title-type="running-head">Reproductive factors, DNA methylation and BC risk</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0170-2592</contrib-id>
                  <name>
                    <surname>Collin</surname>
                    <given-names>Lindsay J.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McCullough</surname>
                    <given-names>Lauren E.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Conway</surname>
                    <given-names>Kathleen</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>White</surname>
                    <given-names>Alexandra J.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Xu</surname>
                    <given-names>Xinran</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cho</surname>
                    <given-names>Yoon Hee</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shantakumar</surname>
                    <given-names>Sumitra</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Teitelbaum</surname>
                    <given-names>Susan L.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Neugut</surname>
                    <given-names>Alfred I.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff008">
                    <sup>8</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff009">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Santella</surname>
                    <given-names>Regina M.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff010">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chen</surname>
                    <given-names>Jia</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Funding acquisition</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff011">
                    <sup>11</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff012">
                    <sup>12</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gammon</surname>
                    <given-names>Marilie D.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Funding acquisition</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Epidemiology, Emory University, Atlanta, GA, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Epidemiology, University of North Carolina, Chapel Hill, NC, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Epidemiology Branch, National Institute of Environmental Health Science, Research Triangle Park, NC, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Roche Product Development in Asia-Pacific, Shanghai, China</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States of America</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>Glaxo-Smith-Kline, Inc., Singapore</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>Department of Epidemiology, Columbia University, New York, NY,United States of America</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>Department of Medicine, Columbia University, New York, NY, United States of America</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>Department of Environmental Health, Columbia University, New York, NY, United States of America</addr-line>
              </aff>
              <aff id="aff011">
                <label>11</label>
                <addr-line>Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America</addr-line>
              </aff>
              <aff id="aff012">
                <label>12</label>
                <addr-line>Department of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Ahmad</surname>
                    <given-names>Aamir</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>University of South Alabama Mitchell Cancer Institute, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>I have read the journal's policy and the authors of this manuscript have the following competing interests: S. Shantakumar is employed at Glaxosmithkline and owns shares. X. Xu is employed by Roche Product Development. A. Neugut serves as a consultant for Otsuka Pharmaceuticals, Pfizer, Eisai, Hospira, Teva, and United Biosource Corp, and is also a member of the medical advisory board of EHE Intl. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>lindsay.jane.collin@emory.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>14</day>
                <month>2</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2019</year>
              </pub-date>
              <volume>14</volume>
              <issue>2</issue>
              <elocation-id>e0210884</elocation-id>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>8</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>3</day>
                  <month>1</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2019 Collin et al</copyright-statement>
                <copyright-year>2019</copyright-year>
                <copyright-holder>Collin et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0210884.pdf"/>
              <abstract>
                <p>DNA methylation has been implicated in breast cancer aetiology, but little is known about whether reproductive history and DNA methylation interact to influence carcinogenesis. This study examined modification of the association between global DNA methylation and breast cancer risk by reproductive characteristics. A population-based case-control study assessed reproductive history in an interviewer-administered questionnaire. Global DNA methylation was measured from white blood cell DNA using luminometric methylation assay (LUMA) and pyrosequencing assay (long interspersed elements-1 (LINE-1). We estimated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) among 1 070 breast cancer cases and 1 110 population-based controls. Effect modification was assessed on additive and multiplicative scales. LUMA methylation was associated with elevated breast cancer risk across all strata (comparing the highest to the lowest quartile), but estimates were higher among women with age at menarche ≤12 years (OR = 2.87, 95%CI = 1.96–4.21) compared to &gt;12 years (OR = 1.66, 95%CI = 1.20–2.29). We observed a 2-fold increase in the LUMA methylation-breast cancer association among women with age at first birth &gt;23 years (OR = 2.62, 95%CI = 1.90–3.62) versus ≤23 years (OR = 1.32, 95% CI = 0.84–2.05). No modification was evident for parity or lactation. Age at menarche and age at first birth may be modifiers of the association between global DNA methylation and breast cancer risk.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>UO1CA/ES66572</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Gammon</surname>
                      <given-names>Marilie D.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000054</institution-id>
                      <institution>National Cancer Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01CA109753</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Jia</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000054</institution-id>
                      <institution>National Cancer Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>3R01CA109753-04S1</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Jia</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This work was supported, in part, by grants from the National Cancer Institute at the National Institutes of Health [Grant numbers UO1CA/ES66572 (PI: MG), R01CA109753 (PI: JC) and 3R01CA109753-04S1 (PI JC)] and the intramural program of the NIH Z99 ES99999. The funders had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript. X. Xu is employed by Roche Product Development. Roche Product Development provided support in the form of salary for author XX, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. S. Shantakumar is employed by Glaxo-Smith-Kline, Inc. Glaxo-Smith-Kline, Inc. provided support in the form of salary for author SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="1"/>
                <table-count count="3"/>
                <page-count count="13"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Data cannot be made publicly available due to ethical and legal restrictions. Ethically, public availability would compromise participants confidentiality as the minimal data-set would include information on the age, sex, and reproductive characteristics of women in a specific geographic region within a limited time-frame. Legally, the investigation began in 1993 under Public Law 103-43, with funding and coordination provided by the National Cancer Institute (NCI), in collaboration with the National Institute of Environmental Health Sciences (NIEHS). Given that our data are sensitive, federally mandated, and were collected prior to NIH public access policies, we are restricted not to disclose data to a third party. While data sharing agreements prohibit us from making the data set publicly available, access may be granted by request to the Study PI (Dr. Marilie Gammon, <email>gammon@unc.edu</email>) who is ultimately responsible for maintaining the confidentiality and integrity of the data. Per Institutional Review Board and data agreements that occurred at the beginning of the study, Dr. Marilie Gammon is required to be the point of contact for data requests. Approvals should obtained by the Institutional Review Boards of the University of North Carolina at Chapel Hill (<email>irb_questions@unc.edu</email>), Columbia University (<email>irboffice@columbia.edu</email>), and Mt. Sinai (<email>IRB@mssm.edu</email>).</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Data cannot be made publicly available due to ethical and legal restrictions. Ethically, public availability would compromise participants confidentiality as the minimal data-set would include information on the age, sex, and reproductive characteristics of women in a specific geographic region within a limited time-frame. Legally, the investigation began in 1993 under Public Law 103-43, with funding and coordination provided by the National Cancer Institute (NCI), in collaboration with the National Institute of Environmental Health Sciences (NIEHS). Given that our data are sensitive, federally mandated, and were collected prior to NIH public access policies, we are restricted not to disclose data to a third party. While data sharing agreements prohibit us from making the data set publicly available, access may be granted by request to the Study PI (Dr. Marilie Gammon, <email>gammon@unc.edu</email>) who is ultimately responsible for maintaining the confidentiality and integrity of the data. Per Institutional Review Board and data agreements that occurred at the beginning of the study, Dr. Marilie Gammon is required to be the point of contact for data requests. Approvals should obtained by the Institutional Review Boards of the University of North Carolina at Chapel Hill (<email>irb_questions@unc.edu</email>), Columbia University (<email>irboffice@columbia.edu</email>), and Mt. Sinai (<email>IRB@mssm.edu</email>).</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Breast cancer remains the most commonly diagnosed invasive cancer among women in the United States [<xref rid="pone.0210884.ref001" ref-type="bibr">1</xref>]. Breast carcinogenesis is a multi-stage process involving both genetic and epigenetic changes [<xref rid="pone.0210884.ref002" ref-type="bibr">2</xref>], the latter defined as changes in gene expression, independent of modifications to the gene sequence [<xref rid="pone.0210884.ref003" ref-type="bibr">3</xref>]. Epigenetic aberrations have been implicated in breast carcinogenesis [<xref rid="pone.0210884.ref004" ref-type="bibr">4</xref>–<xref rid="pone.0210884.ref006" ref-type="bibr">6</xref>] and, unlike genetic alterations, these modifications may be altered across the lifespan by both exogenous and endogenous factors [<xref rid="pone.0210884.ref007" ref-type="bibr">7</xref>]. One commonly studied epigenetic modification is DNA methylation, characterized as the addition of a methyl group (-CH<sub>3</sub>) to the 5-carbon position of cytosine CpG dinucleotides [<xref rid="pone.0210884.ref008" ref-type="bibr">8</xref>]. DNA methylation is a regulatory mechanism for gene expression and may influence cancer development through activation or silencing of genes involved in tumorigenesis [<xref rid="pone.0210884.ref008" ref-type="bibr">8</xref>]. In addition to gene-specific DNA methylation, global DNA hypomethylation in regions that are normally methylated (i.e., tandem repeats or transposable elements) can lead to genomic instability and oncogene expression in breast tissue [<xref rid="pone.0210884.ref008" ref-type="bibr">8</xref>]. We previously reported that breast cancer risk was increased among women in the highest level of luminometric methylation assay (LUMA), but no association was observed when we considered long interspersed elements-1 (LINE-1) methylation in white blood cell (WBC) DNA [<xref rid="pone.0210884.ref009" ref-type="bibr">9</xref>].</p>
              <p>Reproductive history, which comprises a group of well-established risk factors for breast cancer, contributes modestly to overall risk [<xref rid="pone.0210884.ref010" ref-type="bibr">10</xref>]; affecting the lifetime cumulative exposure of the breast epithelium to endogenous ovarian steroid hormones [<xref rid="pone.0210884.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0210884.ref012" ref-type="bibr">12</xref>]. Prior studies have shown that age at first birth and parity alter the methylation profile of CpGs related to ERα expression in non-malignant breast tissue [<xref rid="pone.0210884.ref013" ref-type="bibr">13</xref>]. Another previous investigation in 376 healthy women showed reproductive characteristics were inversely associated with markers of global methylation as measured by LUMA [<xref rid="pone.0210884.ref014" ref-type="bibr">14</xref>]. However, this study was limited to menarcheal age and did not explore the potential links to breast cancer incidence. While both reproductive characteristics and aberrant DNA methylation are known to be relevant to breast cancer, no previous research has investigated their potential interaction with respect to breast cancer risk. Cyclical DNA methylation/demethylation may be activated by steroid hormones [<xref rid="pone.0210884.ref015" ref-type="bibr">15</xref>], modulating the expression of steroid receptors. It is therefore biologically plausible that reproductive characteristics and DNA methylation have a joint effect on breast carcinogenesis.</p>
              <p>In this current study, we sought to expand our previous work on the association between global DNA methylation and breast cancer risk by examining the potential modification of the association between global DNA methylation and breast cancer risk by age at menarche, age at first birth, parity, and lactation. We used two independent methods to assess global DNA methylation in WBC DNA. The first is a pyrosequencing assay, which measures methylation levels in repetitive, LINE-1; this method is commonly used as a surrogate marker of genome-wide DNA methylation [<xref rid="pone.0210884.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0210884.ref017" ref-type="bibr">17</xref>]. The second method, LUMA, measures the levels of 5-<sup>m</sup>C in the C<sup>m</sup>CGG motif which allows approximation of methylation levels at gene promoters rather than the total genome [<xref rid="pone.0210884.ref009" ref-type="bibr">9</xref>]. We also investigated whether reproductive characteristics were associated with global methylation in controls. We hypothesized that reproductive factors would modify the association between global DNA methylation and breast cancer risk.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Materials and methods</title>
              <p>Existing resources from the population-based case-control Long Island Breast Cancer Study Project (LIBCSP) were used to conduct our ancillary study. Details of participant recruitment, study design, and cohort characteristics have been described elsewhere [<xref rid="pone.0210884.ref018" ref-type="bibr">18</xref>]. All participating institutions obtained Institutional Review Board approval.</p>
              <sec id="sec003">
                <title>Study population and study interview</title>
                <p>Study participants in the LIBCSP were English-speaking female residents of Nassau and Suffolk counties of Long Island, New York [<xref rid="pone.0210884.ref018" ref-type="bibr">18</xref>]. Cases were defined as women with a newly diagnosed first primary breast cancer between August 1, 1996 and July 31, 1997, and were identified through daily or weekly contact with the local hospital pathology departments. Population-based controls were randomly selected using random digit dialling for women under age 65 and Health Care Finance Administration rosters for women ages 65 and older. Controls were frequency matched to the expected age distribution of case women by 5-year age groups.</p>
                <p>Interviews were completed for 82.1% (n = 1 508) of eligible cases and 62.8% (n = 1 556) of controls [<xref rid="pone.0210884.ref018" ref-type="bibr">18</xref>] (<bold><xref ref-type="fig" rid="pone.0210884.g001">Fig 1</xref></bold>). As abstracted from the medical/pathology records of the case women, 84.4% (n = 1 273) were diagnosed with invasive breast cancer, and 73.3% (of the 990 for whom this information was available) presented with estrogen receptor positive (ER+) breast cancer. Also, among all case-control participants, age at diagnosis (at identification for controls) ranged from 20 to 98 years, 67.1% were determined to be postmenopausal, and 92.8% were white (which is consistent with the underlying race distribution of the study counties at the time of data collection) [<xref rid="pone.0210884.ref018" ref-type="bibr">18</xref>] (<bold><xref rid="pone.0210884.t001" ref-type="table">Table 1</xref></bold>). We previously reported that, among the LIBCSP population, increased breast cancer risk was associated with: early age at menarche, parity or nulliparity, late age at first birth, and little or no lactation [<xref rid="pone.0210884.ref019" ref-type="bibr">19</xref>]; and higher average lifetime alcohol intake [<xref rid="pone.0210884.ref020" ref-type="bibr">20</xref>]. Age-and menopausal-specific associations were also found for: use of oral contraceptives and hormone replacement therapy [<xref rid="pone.0210884.ref021" ref-type="bibr">21</xref>], adult weight gain [<xref rid="pone.0210884.ref022" ref-type="bibr">22</xref>]; increased body size and little or no physical activity [<xref rid="pone.0210884.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0210884.ref024" ref-type="bibr">24</xref>].</p>
                <fig id="pone.0210884.g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0210884.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Selection and response of study population based on inclusion criteria of subjects in the population-based case control study of women age 20–98, in the Long Island Breast Cancer Study Project.</title>
                  </caption>
                  <graphic xlink:href="pone.0210884.g001"/>
                </fig>
                <table-wrap id="pone.0210884.t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0210884.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Distribution of demographic and clinical characteristics by case-control status among the 1070 cases and 1110 controls with available global methylation data, Long Island Breast Cancer Study Project.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0210884.t001g" xlink:href="pone.0210884.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Case (1070)</th>
                          <th align="center" rowspan="1" colspan="1">Control (1110)</th>
                        </tr>
                        <tr>
                          <th align="center" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">N (%)</th>
                          <th align="center" rowspan="1" colspan="1">N (%)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Age at diagnosis</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">&lt;50 years</td>
                          <td align="center" rowspan="1" colspan="1">294 (27.5)</td>
                          <td align="center" rowspan="1" colspan="1">371 (33.4)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">≥50 years</td>
                          <td align="center" rowspan="1" colspan="1">776 (72.5)</td>
                          <td align="center" rowspan="1" colspan="1">739 (66.6)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Menopausal status</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Premenopausal</td>
                          <td align="center" rowspan="1" colspan="1">376 (35.1)</td>
                          <td align="center" rowspan="1" colspan="1">376 (33.9)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Postmenopausal</td>
                          <td align="center" rowspan="1" colspan="1">703 (65.7)</td>
                          <td align="center" rowspan="1" colspan="1">688 (66.1)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Missing</td>
                          <td align="center" rowspan="1" colspan="1">25</td>
                          <td align="center" rowspan="1" colspan="1">46</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Cigarette Smoking</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Never</td>
                          <td align="center" rowspan="1" colspan="1">491 (45.9)</td>
                          <td align="center" rowspan="1" colspan="1">502 (45.3)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Current</td>
                          <td align="center" rowspan="1" colspan="1">205 (19.1)</td>
                          <td align="center" rowspan="1" colspan="1">209 (18.9)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Former</td>
                          <td align="center" rowspan="1" colspan="1">374 (35.0)</td>
                          <td align="center" rowspan="1" colspan="1">397 (35.8)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Missing</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">2</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Age at menarche</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Less than 12 years</td>
                          <td align="center" rowspan="1" colspan="1">457 (43.1)</td>
                          <td align="center" rowspan="1" colspan="1">484 (43.9)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">12 years or older</td>
                          <td align="center" rowspan="1" colspan="1">604 (56.9)</td>
                          <td align="center" rowspan="1" colspan="1">619 (56.1)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Missing</td>
                          <td align="center" rowspan="1" colspan="1">9</td>
                          <td align="center" rowspan="1" colspan="1">7</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Parity</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Nulliparous</td>
                          <td align="center" rowspan="1" colspan="1">140 (13.1)</td>
                          <td align="center" rowspan="1" colspan="1">124 (11.2)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Parous</td>
                          <td align="center" rowspan="1" colspan="1">930 (86.9)</td>
                          <td align="center" rowspan="1" colspan="1">986 (88.8)</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" rowspan="1">Age at first birth (among parous women only)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Less than 23 years</td>
                          <td align="center" rowspan="1" colspan="1">314 (33.8)</td>
                          <td align="center" rowspan="1" colspan="1">355 (36.0)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">23–27 years</td>
                          <td align="center" rowspan="1" colspan="1">310 (33.4)</td>
                          <td align="center" rowspan="1" colspan="1">345 (35.0)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Over 27 years</td>
                          <td align="center" rowspan="1" colspan="1">305 (32.8)</td>
                          <td align="center" rowspan="1" colspan="1">286 (29.0)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Missing</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="2" rowspan="1">Lactation (among parous women only)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Never</td>
                          <td align="center" rowspan="1" colspan="1">566 (60.9)</td>
                          <td align="center" rowspan="1" colspan="1">580 (58.8)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Any</td>
                          <td align="center" rowspan="1" colspan="1">364 (39.1)</td>
                          <td align="center" rowspan="1" colspan="1">406 (41.2)</td>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">ER Status</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Positive</td>
                          <td align="center" rowspan="1" colspan="1">422 (61.1)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Negative</td>
                          <td align="center" rowspan="1" colspan="1">269 (38.9)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="right" rowspan="1" colspan="1">Missing</td>
                          <td align="center" rowspan="1" colspan="1">379</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>At the time of the case-control interview (which for cases occurred approximately two to three months after diagnosis), trained and licensed phlebotomists/nurses obtained a non-fasting blood sample from 73.1% of cases (N = 1 102) and 73.3% (N = 1 140) of control participants, which for most women occurred prior to adjuvant therapy. Study participants who agreed to donate a blood sample were generally younger than those who declined [<xref rid="pone.0210884.ref018" ref-type="bibr">18</xref>]. DNA was isolated from the donated blood samples using methods previously described [<xref rid="pone.0210884.ref025" ref-type="bibr">25</xref>].</p>
                <p>Written informed consent was obtained from all participants prior to the study questionnaire, and prior to phlebotomy.</p>
              </sec>
              <sec id="sec004">
                <title>Global methylation</title>
                <p>Details of global methylation assessment within the LIBCSP study population have been described in detail [<xref rid="pone.0210884.ref009" ref-type="bibr">9</xref>]. Briefly, LUMA methylation levels were expressed as a percentage based on the following equation: methylation (%) = [1-(<italic>HpaII</italic> ∑G/∑T)/(<italic>MspI</italic> ∑G/∑T)]*100.[<xref rid="pone.0210884.ref026" ref-type="bibr">26</xref>] LINE-1 methylation levels were assessed using a previously validated pyrosequencing assay to assess 4 CpG sites in its promoter region [<xref rid="pone.0210884.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0210884.ref028" ref-type="bibr">28</xref>]. Methylation status at each of the four loci were analysed individual as a T/C single nucleotide polymorphism using QCpG software (Qiagen) and then averaged to provide an overall percentage 5<sup>m</sup>C status. As a quality control measure, to examine possible batch effects, samples were randomly selected for replication. Cases and controls were assayed simultaneously with the laboratory personnel blinded to both case-control status and quality control status. Of the 1 102 cases and 1 140 controls with available blood, 1 070 cases (97.1%) and 1 110 controls (97.4%) had valid global methylation data and were included in the study reported here.</p>
              </sec>
              <sec id="sec005">
                <title>Reproductive characteristics</title>
                <p>The reproductive characteristics of interest for our study were age at menarche, parity, age at first birth, and lactation. These variables were collected as part of the main 100-minute interviewer-administered questionnaire, which included a reproductive calendar to enhance recall [<xref rid="pone.0210884.ref029" ref-type="bibr">29</xref>]. For the purposes of this ancillary study, age at menarche was dichotomized at 12 years of age, and parity was categorized as nulliparous versus parous. Among parous women, age at first birth was dichotomized at 23 years of age, and women with any lactation were compared to women without lactation. These categorizations were based on previously published data in our study population [<xref rid="pone.0210884.ref019" ref-type="bibr">19</xref>], optimization of cell counts, and incorporation of biologic plausibility. We explored a three-level category for age at first birth (≤23, 23–27, ≥27 years of age), but observed similar effect estimates in the 23–27 and ≥27 categories. We therefore collapsed these two groups in our final analysis.</p>
              </sec>
              <sec id="sec006">
                <title>Statistical methods</title>
                <p>Using unconditional logistic regression we first estimated odds ratios (ORs) and 95% confidence intervals (CI) for the associations between reproductive characteristics and global methylation levels, among control women only (n = 1 110, 88.8% parous), given previous evidence that women with breast cancer (compared to women without breast cancer) are likely to have lower global methylation levels [<xref rid="pone.0210884.ref030" ref-type="bibr">30</xref>]. Then, using information from both cases and controls (2 180 women, 87.9% parous), we evaluated whether the association between global methylation and breast cancer risk was modified by reproductive history. Finally, as a sensitivity analysis, we also explored whether reproductive characteristics modified the association between global DNA methylation and ER+ breast cancer, given that sex-steroid hormones are a potential unifying mechanism for DNA methylation, reproductive characteristics and breast cancer risk [<xref rid="pone.0210884.ref015" ref-type="bibr">15</xref>].</p>
                <p>We estimated the odds of breast cancer within quartiles of LUMA and LINE-1 global methylation markers and within strata of each of the four reproductive characteristics. For associations stratified by age at menarche and parity, models included all women (n = 2 180), but for age at first birth or lactation, models included parous women only (n = 1 916). Quartiles (Q) of LUMA and LINE-1 methylation were categorized based on distribution of the percent methylation among controls. Given that LUMA, a global measurement of promoter methylation, was positively associated with overall breast cancer risk in our study population (9), we used the lowest quartile as the referent category. In contrast, LINE-1 hypomethylation is hypothesized to be a marker of decreased genomic integrity, we therefore used the highest quartile of LINE-1 as the referent category.</p>
                <p>Effect modification between global methylation and reproductive characteristics in association with breast cancer incidence was assessed on multiplicative and additive scales. Multiplicative interactions were evaluated using stratification and by comparing nested models with and without the interaction term using a Likelihood Ratio Test (<italic>a priori</italic> p-value &lt;0.05). Additive interactions were evaluated using a common referent and the relative excess risk due to interaction (RERI) [<xref rid="pone.0210884.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0210884.ref032" ref-type="bibr">32</xref>] and corresponding 95% CIs calculated using the delta method [<xref rid="pone.0210884.ref032" ref-type="bibr">32</xref>].</p>
                <p>For all models, potential confounders were first selected using directed acyclic graphs (DAGs). Potential covariates included: family history of breast cancer (no/yes), history of benign breast disease (no/yes), race (white/black/other), use of oral contraceptives (never/ever), body mass index (BMI, &lt;25 kg/m<sup>2</sup>, 25–29.9 kg/m<sup>2</sup>, ≥30 kg/m<sup>2</sup>), recreational physical activity (RPA, high/moderate/inactive), alcohol history (never/ever), and smoking history (never/former/current). We further considered each possible confounder for inclusion in the final models based on a &gt;10% change in estimate approach [<xref rid="pone.0210884.ref033" ref-type="bibr">33</xref>], but none met this criteria. Thus, final models presented here only include the frequency matching factor age (5-year age groups).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec007">
              <title>Results</title>
              <p>Among control women, we observed no associations between any reproductive characteristic and LUMA or LINE-1 methylation levels. Observed estimates were at or near the null, with all confidence intervals including the null (<bold><xref ref-type="supplementary-material" rid="pone.0210884.s001">S1 Table</xref></bold>).</p>
              <sec id="sec008">
                <title>Age at menarche</title>
                <p>As shown in <bold><xref rid="pone.0210884.t002" ref-type="table">Table 2</xref>,</bold> among women with age of menarche ≤12 years of age, breast cancer risk increased within each increasing quartile of LUMA methylation, compared to the lowest quartile (OR<sub>Q2</sub> = 1.47, 95%CI = 0.98–2.20; OR<sub>Q3</sub> = 2.23, 95%CI = 1.51–3.29; OR<sub>Q4</sub> = 2.87, 95%CI = 1.96–4.21). A non-monotonic increase in breast cancer risk with increasing LUMA methylation was also observed among those with age at menarche &gt;12 years of age, although the effect estimate was less pronounced (OR = 1.66, 95%CI = 1.20–2.29, comparing Q4 vs. Q1). This effect modification of the LUMA methylation-breast cancer association by age at menarche was evident on the multiplicative (p<sub>interaction</sub> = 0.05), but not the additive scale [the RERI for additive interaction comparing those reporting an age at menarche ≤12 years and the highest level of global methylation assessed by LUMA (doubly exposed) to those with age at menarche &gt;12 years and the lowest LUMA methylation levels (referent) was 0.19 (95%CI = -0.38–0.76)], [<bold><xref ref-type="supplementary-material" rid="pone.0210884.s002">S2 Table</xref></bold>].</p>
                <table-wrap id="pone.0210884.t002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0210884.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Age-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the multiplicative interaction between the luminometric methylation assay (LUMA) and reproductive characteristics (age at menarche, age at first birth, parity, lactation) with breast cancer risk in a population-based sample of 2180 women with available global methylation data, Long Island Breast Cancer Study Project.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0210884.t002g" xlink:href="pone.0210884.t002"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">LUMA (Quartiles)</th>
                          <th align="center" rowspan="1" colspan="1">Cases/<break/>Controls</th>
                          <th align="center" rowspan="1" colspan="1">OR</th>
                          <th align="center" rowspan="1" colspan="1">95% CI</th>
                          <th align="center" rowspan="1" colspan="1">Cases/<break/>Controls</th>
                          <th align="center" rowspan="1" colspan="1">OR</th>
                          <th align="center" rowspan="1" colspan="1">95% CI</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="6" rowspan="1">
                            <bold>Age at Menarche</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="3" rowspan="1">&gt;12 years</td>
                          <td align="center" colspan="3" rowspan="1">≤12 years</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q1 (&lt;0.43)</td>
                          <td align="center" rowspan="1" colspan="1">115/142</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                          <td align="center" rowspan="1" colspan="1">66/131</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q2 (0.43&lt;0.56)</td>
                          <td align="center" rowspan="1" colspan="1">92/156</td>
                          <td align="center" rowspan="1" colspan="1">0.72</td>
                          <td align="center" rowspan="1" colspan="1">0.50–1.02</td>
                          <td align="center" rowspan="1" colspan="1">90/118</td>
                          <td align="center" rowspan="1" colspan="1">1.47</td>
                          <td align="center" rowspan="1" colspan="1">0.98–2.20</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q3 (0.56&lt;0.66)</td>
                          <td align="center" rowspan="1" colspan="1">170/154</td>
                          <td align="center" rowspan="1" colspan="1">1.36</td>
                          <td align="center" rowspan="1" colspan="1">0.97–1.89</td>
                          <td align="center" rowspan="1" colspan="1">133/119</td>
                          <td align="center" rowspan="1" colspan="1">2.23</td>
                          <td align="center" rowspan="1" colspan="1">1.51–3.29</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q4 (≥0.66)</td>
                          <td align="center" rowspan="1" colspan="1">215/161</td>
                          <td align="center" rowspan="1" colspan="1">1.66</td>
                          <td align="center" rowspan="1" colspan="1">1.20–2.29</td>
                          <td align="center" rowspan="1" colspan="1">165/113</td>
                          <td align="center" rowspan="1" colspan="1">2.87</td>
                          <td align="center" rowspan="1" colspan="1">1.96–4.21</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="left" colspan="3" rowspan="1"><italic>multiplicative p = 0</italic>.<italic>05</italic></td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="6" rowspan="1">
                            <bold>Parity</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="3" rowspan="1">Parous</td>
                          <td align="center" colspan="3" rowspan="1">Nulliparous</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q1 (&lt;0.43)</td>
                          <td align="center" rowspan="1" colspan="1">160/250</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                          <td align="center" rowspan="1" colspan="1">23/26</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q2 (0.43&lt;0.56)</td>
                          <td align="center" rowspan="1" colspan="1">161/240</td>
                          <td align="center" rowspan="1" colspan="1">1.02</td>
                          <td align="center" rowspan="1" colspan="1">0.77–1.36</td>
                          <td align="center" rowspan="1" colspan="1">22/35</td>
                          <td align="center" rowspan="1" colspan="1">0.74</td>
                          <td align="center" rowspan="1" colspan="1">0.34–1.63</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q3 (0.56&lt;0.66)</td>
                          <td align="center" rowspan="1" colspan="1">274/244</td>
                          <td align="center" rowspan="1" colspan="1">1.74</td>
                          <td align="center" rowspan="1" colspan="1">1.34–2.27</td>
                          <td align="center" rowspan="1" colspan="1">32/30</td>
                          <td align="center" rowspan="1" colspan="1">1.32</td>
                          <td align="center" rowspan="1" colspan="1">0.61–2.83</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q4 (≥0.66)</td>
                          <td align="center" rowspan="1" colspan="1">324/243</td>
                          <td align="center" rowspan="1" colspan="1">2.08</td>
                          <td align="center" rowspan="1" colspan="1">1.60–2.69</td>
                          <td align="center" rowspan="1" colspan="1">59/33</td>
                          <td align="center" rowspan="1" colspan="1">2.13</td>
                          <td align="center" rowspan="1" colspan="1">1.04–4.37</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="left" colspan="3" rowspan="1"><italic>multiplicative p = 0</italic>.<italic>70</italic></td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="6" rowspan="1">
                            <bold>Age at First Birth</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="3" rowspan="1">≤23 years</td>
                          <td align="center" colspan="3" rowspan="1">&gt;23 years</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q1 (&lt;0.43)</td>
                          <td align="center" rowspan="1" colspan="1">58/82</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                          <td align="center" rowspan="1" colspan="1">102/168</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q2 (0.43&lt;0.56)</td>
                          <td align="center" rowspan="1" colspan="1">61/88</td>
                          <td align="center" rowspan="1" colspan="1">0.93</td>
                          <td align="center" rowspan="1" colspan="1">0.58–1.49</td>
                          <td align="center" rowspan="1" colspan="1">99/152</td>
                          <td align="center" rowspan="1" colspan="1">1.06</td>
                          <td align="center" rowspan="1" colspan="1">0.74–1.51</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q3 (0.56&lt;0.66)</td>
                          <td align="center" rowspan="1" colspan="1">101/84</td>
                          <td align="center" rowspan="1" colspan="1">1.65</td>
                          <td align="center" rowspan="1" colspan="1">1.05–2.58</td>
                          <td align="center" rowspan="1" colspan="1">173/160</td>
                          <td align="center" rowspan="1" colspan="1">1.78</td>
                          <td align="center" rowspan="1" colspan="1">1.28–2.47</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q4 (≥0.66)</td>
                          <td align="center" rowspan="1" colspan="1">91/97</td>
                          <td align="center" rowspan="1" colspan="1">1.32</td>
                          <td align="center" rowspan="1" colspan="1">0.84–2.05</td>
                          <td align="center" rowspan="1" colspan="1">233/146</td>
                          <td align="center" rowspan="1" colspan="1">2.62</td>
                          <td align="center" rowspan="1" colspan="1">1.90–3.62</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="left" colspan="3" rowspan="1"><italic>multiplicative p = 0</italic>.<italic>02</italic></td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="6" rowspan="1">
                            <bold>Lactation</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="3" rowspan="1">Any</td>
                          <td align="center" colspan="3" rowspan="1">Never</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q1 (&lt;0.43)</td>
                          <td align="center" rowspan="1" colspan="1">98/148</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                          <td align="center" rowspan="1" colspan="1">62/102</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q2 (0.43&lt;0.56)</td>
                          <td align="center" rowspan="1" colspan="1">98/136</td>
                          <td align="center" rowspan="1" colspan="1">1.06</td>
                          <td align="center" rowspan="1" colspan="1">0.74–1.53</td>
                          <td align="center" rowspan="1" colspan="1">63/104</td>
                          <td align="center" rowspan="1" colspan="1">0.97</td>
                          <td align="center" rowspan="1" colspan="1">0.62–1.51</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q3 (0.56&lt;0.66)</td>
                          <td align="center" rowspan="1" colspan="1">172/142</td>
                          <td align="center" rowspan="1" colspan="1">1.83</td>
                          <td align="center" rowspan="1" colspan="1">1.30–2.57</td>
                          <td align="center" rowspan="1" colspan="1">102/102</td>
                          <td align="center" rowspan="1" colspan="1">1.62</td>
                          <td align="center" rowspan="1" colspan="1">1.07–2.47</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q4 (≥0.66)</td>
                          <td align="center" rowspan="1" colspan="1">191/150</td>
                          <td align="center" rowspan="1" colspan="1">1.91</td>
                          <td align="center" rowspan="1" colspan="1">1.37–2.67</td>
                          <td align="center" rowspan="1" colspan="1">122/93</td>
                          <td align="center" rowspan="1" colspan="1">2.35</td>
                          <td align="center" rowspan="1" colspan="1">1.55–3.55</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" colspan="3" rowspan="1"><italic>multiplicative p = 0</italic>.<italic>50</italic></td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>As shown in <bold><xref rid="pone.0210884.t003" ref-type="table">Table 3</xref>,</bold> the association between LINE-1 methylation and breast cancer risk (comparing Q1 vs. Q4) did not appear to differ between those with age at menarche ≤12 years of age (OR = 1.04, 95%CI = 0.72–1.49) and those who reported an age at menarche &gt;12 years (OR = 1.08, 95%CI = 0.78–1.45).</p>
                <table-wrap id="pone.0210884.t003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0210884.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Age-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the multiplicative interaction between the long-interspersed elements-1 (LINE-1) assay and reproductive characteristics (age at menarche, age at first birth, parity, lactation) with breast cancer risk in a population-based sample of 2180 women with available global methylation data, Long Island Breast Cancer Study Project.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0210884.t003g" xlink:href="pone.0210884.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">LINE-1 (Quartiles)</th>
                          <th align="center" rowspan="1" colspan="1">Cases/<break/>Controls</th>
                          <th align="center" rowspan="1" colspan="1">OR</th>
                          <th align="center" rowspan="1" colspan="1">95% CI</th>
                          <th align="center" rowspan="1" colspan="1">Cases/<break/>Controls</th>
                          <th align="center" rowspan="1" colspan="1">OR</th>
                          <th align="center" rowspan="1" colspan="1">95% CI</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="6" rowspan="1">
                            <bold>Age at Menarche</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="3" rowspan="1">&gt;12 years</td>
                          <td align="center" colspan="3" rowspan="1">≤12 years</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q4 (≥80.4)</td>
                          <td align="center" rowspan="1" colspan="1">154/160</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                          <td align="center" rowspan="1" colspan="1">123/116</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q3 (78.7&lt;80.4)</td>
                          <td align="center" rowspan="1" colspan="1">135/141</td>
                          <td align="center" rowspan="1" colspan="1">1.02</td>
                          <td align="center" rowspan="1" colspan="1">0.73–1.41</td>
                          <td align="center" rowspan="1" colspan="1">101/133</td>
                          <td align="center" rowspan="1" colspan="1">0.72</td>
                          <td align="center" rowspan="1" colspan="1">0.50–1.02</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q2 (77.0&lt;78.7)</td>
                          <td align="center" rowspan="1" colspan="1">149/148</td>
                          <td align="center" rowspan="1" colspan="1">1.06</td>
                          <td align="center" rowspan="1" colspan="1">0.77–1.46</td>
                          <td align="center" rowspan="1" colspan="1">110/123</td>
                          <td align="center" rowspan="1" colspan="1">0.83</td>
                          <td align="center" rowspan="1" colspan="1">0.58–1.19</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q1 (&lt;77.0)</td>
                          <td align="center" rowspan="1" colspan="1">162/163</td>
                          <td align="center" rowspan="1" colspan="1">1.06</td>
                          <td align="center" rowspan="1" colspan="1">0.78–1.45</td>
                          <td align="center" rowspan="1" colspan="1">122/110</td>
                          <td align="center" rowspan="1" colspan="1">1.04</td>
                          <td align="center" rowspan="1" colspan="1">0.72–1.49</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="left" colspan="3" rowspan="1"><italic>multiplicative p = 0</italic>.<italic>43</italic></td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="6" rowspan="1">
                            <bold>Parity</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="3" rowspan="1">Parous</td>
                          <td align="center" colspan="3" rowspan="1">Nulliparous</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q4 (≥80.4)</td>
                          <td align="center" rowspan="1" colspan="1">239/249</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                          <td align="center" rowspan="1" colspan="1">40/27</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q3 (78.7&lt;80.4)</td>
                          <td align="center" rowspan="1" colspan="1">203/240</td>
                          <td align="center" rowspan="1" colspan="1">0.89</td>
                          <td align="center" rowspan="1" colspan="1">0.69–1.15</td>
                          <td align="center" rowspan="1" colspan="1">35/34</td>
                          <td align="center" rowspan="1" colspan="1">0.77</td>
                          <td align="center" rowspan="1" colspan="1">0.39–1.54</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q2 (77.0&lt;78.7)</td>
                          <td align="center" rowspan="1" colspan="1">225/246</td>
                          <td align="center" rowspan="1" colspan="1">0.95</td>
                          <td align="center" rowspan="1" colspan="1">0.73–1.22</td>
                          <td align="center" rowspan="1" colspan="1">36/29</td>
                          <td align="center" rowspan="1" colspan="1">0.91</td>
                          <td align="center" rowspan="1" colspan="1">0.45–1.85</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q1 (&lt;77.0)</td>
                          <td align="center" rowspan="1" colspan="1">257/243</td>
                          <td align="center" rowspan="1" colspan="1">1.12</td>
                          <td align="center" rowspan="1" colspan="1">0.87–1.44</td>
                          <td align="center" rowspan="1" colspan="1">29/32</td>
                          <td align="center" rowspan="1" colspan="1">0.62</td>
                          <td align="center" rowspan="1" colspan="1">0.30–1.26</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="left" colspan="3" rowspan="1"><italic>multiplicative p = 0</italic>.<italic>41</italic></td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="6" rowspan="1">
                            <bold>Age at First Birth</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="3" rowspan="1">≤23 years</td>
                          <td align="center" colspan="3" rowspan="1">&gt;23 years</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q4 (≥80.4)</td>
                          <td align="center" rowspan="1" colspan="1">82/90</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                          <td align="center" rowspan="1" colspan="1">156/159</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q3 (78.7&lt;80.4)</td>
                          <td align="center" rowspan="1" colspan="1">62/84</td>
                          <td align="center" rowspan="1" colspan="1">0.84</td>
                          <td align="center" rowspan="1" colspan="1">0.54–1.32</td>
                          <td align="center" rowspan="1" colspan="1">141/156</td>
                          <td align="center" rowspan="1" colspan="1">0.92</td>
                          <td align="center" rowspan="1" colspan="1">0.67–1.26</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q2 (77.0&lt;78.7)</td>
                          <td align="center" rowspan="1" colspan="1">72/91</td>
                          <td align="center" rowspan="1" colspan="1">0.88</td>
                          <td align="center" rowspan="1" colspan="1">0.57–1.35</td>
                          <td align="center" rowspan="1" colspan="1">153/155</td>
                          <td align="center" rowspan="1" colspan="1">0.99</td>
                          <td align="center" rowspan="1" colspan="1">0.73–1.36</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q1 (&lt;77.0)</td>
                          <td align="center" rowspan="1" colspan="1">96/88</td>
                          <td align="center" rowspan="1" colspan="1">1.25</td>
                          <td align="center" rowspan="1" colspan="1">0.82–1.90</td>
                          <td align="center" rowspan="1" colspan="1">161/155</td>
                          <td align="center" rowspan="1" colspan="1">1.06</td>
                          <td align="center" rowspan="1" colspan="1">0.67–1.26</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="left" colspan="3" rowspan="1"><italic>multiplicative p = 0</italic>.<italic>75</italic></td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="6" rowspan="1">
                            <bold>Lactation</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" colspan="3" rowspan="1">Any</td>
                          <td align="center" colspan="3" rowspan="1">Never</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q4 (≥80.4)</td>
                          <td align="center" rowspan="1" colspan="1">80/90</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                          <td align="center" rowspan="1" colspan="1">159/159</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">reference</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q3 (78.7&lt;80.4)</td>
                          <td align="center" rowspan="1" colspan="1">93/103</td>
                          <td align="center" rowspan="1" colspan="1">0.80</td>
                          <td align="center" rowspan="1" colspan="1">0.57–1.12</td>
                          <td align="center" rowspan="1" colspan="1">110/137</td>
                          <td align="center" rowspan="1" colspan="1">1.02</td>
                          <td align="center" rowspan="1" colspan="1">0.68–1.55</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q2 (77.0&lt;78.7)</td>
                          <td align="center" rowspan="1" colspan="1">83/105</td>
                          <td align="center" rowspan="1" colspan="1">1.01</td>
                          <td align="center" rowspan="1" colspan="1">0.73–1.39</td>
                          <td align="center" rowspan="1" colspan="1">142/141</td>
                          <td align="center" rowspan="1" colspan="1">0.87</td>
                          <td align="center" rowspan="1" colspan="1">0.57–1.32</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Q1 (&lt;77.0)</td>
                          <td align="center" rowspan="1" colspan="1">107/105</td>
                          <td align="center" rowspan="1" colspan="1">1.11</td>
                          <td align="center" rowspan="1" colspan="1">0.80–1.52</td>
                          <td align="center" rowspan="1" colspan="1">150/138</td>
                          <td align="center" rowspan="1" colspan="1">1.15</td>
                          <td align="center" rowspan="1" colspan="1">0.77–1.73</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> </td>
                          <td align="left" colspan="3" rowspan="1"><italic>multiplicative p = 0</italic>.<italic>53</italic></td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                          <td align="center" rowspan="1" colspan="1"> </td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec009">
                <title>Parity</title>
                <p>The association between LUMA methylation and breast cancer did not appear to differ substantially between strata of parity. When comparing the highest to the lowest quartile, we observed similar ORs between LUMA methylation and breast cancer risk among nulliparous (OR = 2.13, 95%CI = 1.04–4.37) and parous (OR = 2.08, 95%CI = 1.60–2.69) women (<bold><xref rid="pone.0210884.t002" ref-type="table">Table 2</xref></bold>). Similarly, parity did not appear to modify the association between LINE-1 methylation and breast cancer risk (<bold><xref rid="pone.0210884.t003" ref-type="table">Table 3</xref></bold>).</p>
              </sec>
              <sec id="sec010">
                <title>Age at first birth</title>
                <p>As shown in <bold><xref rid="pone.0210884.t002" ref-type="table">Table 2</xref></bold>, among women with an age at first birth &gt;23 years the risk of breast cancer increased with increasing quartiles of LUMA methylation (OR<sub>Q2 vs Q1</sub> = 1.06, 95%CI = 0.74–1.51; OR<sub>Q3 vs Q1</sub> = 1.78, 95%CI = 1.28–2.47; OR<sub>Q4 vs Q1</sub> = 2.62, 95%CI = 1.90–3.62). By comparison, among women reporting early age at first birth (≤23 years) the association with breast cancer among women in the highest LUMA methylation quartile was less pronounced and included the null value (OR = 1.32, 95%CI = 0.84–2.05). This effect modification by age at first birth on the LUMA methylation-breast cancer association was evident on the multiplicative (p<sub>interaction</sub> = 0.02) and additive scales [the observed RERI was 1.07 (95%CI = 0.43–1.71) comparing women with a first birth &gt;23 years of age and the highest quartile of LUMA methylation (doubly exposed) to those with a first birth ≤23 years and the lowest quartile of LUMA methylation (referent).</p>
                <p>Age at first birth did not appear to modify the association between LINE-1 methylation and breast cancer risk (<bold><xref rid="pone.0210884.t003" ref-type="table">Table 3</xref></bold>). For women in the lowest quartile of LINE-1 methylation, there was a 25% increased risk of breast cancer within the strata of age at first birth ≤23 years, (OR = 1.25, 95%CI = 0.82–1.90) as compared with a 6% increased risk within the strata of age at first birth &gt;23 (OR = 1.06, 95%CI = 0.67–1.26). We also considered a three-category variable (&lt;23, 23–27, &gt;27) for age at first birth, but found similar effect estimates among those with a first birth between 23–27 years of age and those &gt;27 years of age (<bold><xref ref-type="supplementary-material" rid="pone.0210884.s003">S3 Table</xref></bold>).</p>
              </sec>
              <sec id="sec011">
                <title>Lactation</title>
                <p>The association between LUMA methylation and breast cancer risk was relatively homogenous across strata of lactation (<bold><xref rid="pone.0210884.t002" ref-type="table">Table 2</xref></bold>). Comparing women in the highest quartile of LUMA methylation to the lowest, we observed around a 2-fold increase in the risk for breast cancer within the never lactating strata (OR = 2.35, 95%CI 1.55–3.55), as well as the ever lactating strata (OR = 1.91, 95%CI = 1.37–2.67) women. We additionally found no evidence for heterogeneity by lactation for the association between LINE-1 methylation and breast cancer (<bold><xref rid="pone.0210884.t003" ref-type="table">Table 3</xref></bold>).</p>
              </sec>
              <sec id="sec012">
                <title>Sensitivity analysis</title>
                <p>In models restricted to ER+ breast cancer only, our results were similar to those shown, although the effect estimates were less precise (<bold><xref ref-type="supplementary-material" rid="pone.0210884.s004">S4 Table</xref></bold>).</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec013">
              <title>Discussion</title>
              <p>In this population-based case-control study, we found that the association between global methylation, measured by LUMA in peripheral blood DNA, and breast cancer risk may depend on select reproductive characteristics, namely age at menarche and age at first birth (but not parity or lactation). Specifically, among women with age at menarche ≤12 years, there was nearly a 200% increase in breast cancer risk in association with high LUMA methylation levels; in contrast, the LUMA methylation-breast cancer association was only modestly increased by 66% among women with age at menarche &gt;12 years (multiplicative interaction p = 0.05). Similarly, among women with a first birth &gt;23 years, the association between high LUMA methylation levels and breast cancer risk was increased by greater than 150%; whereas among women with a first birth ≤23 years, the LUMA methylation-breast cancer association was increased by only 32% (multiplicative interaction p value = 0.02) No modification of the LINE-1 methylation-breast cancer association was observed by any of the four reproductive characteristics considered.</p>
              <p>Numerous studies have been published on DNA methylation changes in breast tissue [<xref rid="pone.0210884.ref034" ref-type="bibr">34</xref>],<sup>,</sup>[<xref rid="pone.0210884.ref035" ref-type="bibr">35</xref>]. Less is known about WBC DNA methylation and breast cancer risk, although several studies have emerged. Given that blood biomarkers can be measured repeatedly over time in large populations, they represent a useful tool for uncovering aetiology and ultimately early detection [<xref rid="pone.0210884.ref036" ref-type="bibr">36</xref>]. To our knowledge, this is the first population-based study to examine modification of the association between global methylation and breast cancer risk by multiple reproductive characteristics using two independent global methylation assays measured in WBC. DNA hypomethylation (estimated via LINE-1) increases genomic instability leading to the activation of oncogenes, is likely to operate early in carcinogenesis, and is known to be affected by multiple factors (including age) [<xref rid="pone.0210884.ref037" ref-type="bibr">37</xref>]. In contrast, LUMA provides an overall quantitation of methylation levels at gene promoters [<xref rid="pone.0210884.ref009" ref-type="bibr">9</xref>] which may more directly reflect gene expression, cell proliferation, and other pathways important in cancer promotion or progression. The specificity of this marker may make it a better surrogate for understanding the role of well-defined exposures (<italic>i</italic>.<italic>e</italic>., reproductive characteristics) in cancer risk.</p>
              <p>Contrary to our findings among control women, data from the EPIC-Italy sub-cohort showed that for each yearly increase in age at menarche, the odds of having genome-wide methylation (assessed by LUMA) below median level was increased by 32% (OR = 1.32, 95%CI = 1.14–1.53) [<xref rid="pone.0210884.ref014" ref-type="bibr">14</xref>]. The association between global methylation (assessed via LUMA) and breast cancer risk are mixed. While we previously estimated a 2.41-fold increased risk of breast cancer (OR<sub>quintile 5 vs.1</sub> = 95%CI = 1.83–3.16) comparing quintile 5 vs. 1,[<xref rid="pone.0210884.ref009" ref-type="bibr">9</xref>] others report greater breast cancer risk among women in the lowest tertile of LUMA (OR = 2.86, 95%CI = 1.85–4.44, comparing tertile 1 vs. 3),[<xref rid="pone.0210884.ref038" ref-type="bibr">38</xref>] and still others found no association between measures by LUMA and breast cancer risk [<xref rid="pone.0210884.ref039" ref-type="bibr">39</xref>]. While the distribution of LUMA methylation levels in these studies may be an important consideration, the observed inconstancies highlight the importance of considering reproductive characteristics in combination with peripheral blood methylation and breast cancer [<xref rid="pone.0210884.ref040" ref-type="bibr">40</xref>]. Our data provide preliminary evidence that the presence of early menarche or late age at first birth, and elevated LUMA methylation may be particularly deleterious for breast cancer risk.</p>
              <p>The divergence of the epigenome as a function of age due to stochastic changes in methylation (a phenomena termed “epigenetic drift”[<xref rid="pone.0210884.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0210884.ref042" ref-type="bibr">42</xref>]) may contribute to tumorigenic transformation [<xref rid="pone.0210884.ref042" ref-type="bibr">42</xref>] including chromosomal instability, mutations, genetic recombination, large deletions, or translocations [<xref rid="pone.0210884.ref043" ref-type="bibr">43</xref>]. This divergence may be influenced by different environmental and lifestyle factors throughout an individual’s life course [<xref rid="pone.0210884.ref041" ref-type="bibr">41</xref>]. Exposure of the genome to factors such as smoking and alcohol consumption have been shown to modify the biologic aging process [<xref rid="pone.0210884.ref007" ref-type="bibr">7</xref>]. Chronic stress has also been found to lead to epigenetic alterations and accelerated aging of tissue samples [<xref rid="pone.0210884.ref044" ref-type="bibr">44</xref>]. Furthermore, environmental and other factors, including hormonal changes during an individual’s lifespan, may contribute to the epigenetic alterations [<xref rid="pone.0210884.ref041" ref-type="bibr">41</xref>]. Our hypotheses that reproductive characteristics modify the association of DNA methylation and breast cancer risk relate to the conceptual framework that hormonal changes contribute to epigenetic drift. Our findings, particularly around age-related reproductive characteristics, support this hypothesis.</p>
              <p>Our study has many strengths, namely the availability of global methylation assessments in a well-characterized population-based case-control study with a relatively large sample size. The study included detailed exposure assessment, particularly for reproductive history. Questionnaires were administered by trained interviewers using validated methods to mitigate recall error,[<xref rid="pone.0210884.ref045" ref-type="bibr">45</xref>] however, exposure was assessed retrospectively and may suffer from differential misclassification by case-control status. Nonetheless, it is unlikely that women knew their methylation status and thus any differential recall of reproductive characteristics would not likely bias the interaction parameters. Because global methylation was assessed in cases shortly after diagnosis, there is concern for reverse causality. However, in a nested case-control study, investigators of the Sister Study Cohort showed that aberrant DNA methylation (assessed in blood) was present in women some 5 years prior to diagnosis and was predictive of breast cancer risk [<xref rid="pone.0210884.ref046" ref-type="bibr">46</xref>]. Another consideration of the current study is the racial and ethnic homogeneity of our study population. This limits the generalizability of our findings to primarily white women, who are at the highest risk of developing breast cancer in the United States [<xref rid="pone.0210884.ref047" ref-type="bibr">47</xref>]. Further research in prospective studies with diverse study populations is needed to confirm our findings.</p>
            </sec>
            <sec sec-type="conclusions" id="sec014">
              <title>Conclusions</title>
              <p>Using resources from a large population-based case-control study, we observed that high methylation levels, assessed using the LUMA platform, were differentially associated with breast cancer risk among women with an earlier age at menarche and a later age at first birth. This study provides etiologic insight into how age-related reproductive factors may influence breast cancer risk through its interaction with the DNA methylome. Our findings may also help in the identification of an early biomarker among women who are at an increased risk of breast cancer based on their reproductive history.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec015">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pone.0210884.s001">
                <label>S1 Table</label>
                <caption>
                  <title>Evaluation of the association between reproductive characteristics and DNA methylation among controls.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0210884.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0210884.s002">
                <label>S2 Table</label>
                <caption>
                  <title>Evaluation of the modification of the effect of DNA methylation on breast cancer risk by reproductive characteristics on the additive scale.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0210884.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0210884.s003">
                <label>S3 Table</label>
                <caption>
                  <title>Use of three category age at first birth to evaluate effect modification of the association between DNA methylation and breast cancer risk.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0210884.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0210884.s004">
                <label>S4 Table</label>
                <caption>
                  <title>Sensitivity analysis of the modification of the effect of DNA methylation on breast cancer risk among ER+ breast cancer cases.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0210884.s004.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0210884.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Siegel</surname><given-names>RL</given-names></name>, <name><surname>Miller</surname><given-names>KD</given-names></name>, <name><surname>Jemal</surname><given-names>A</given-names></name>. <article-title>Cancer statistics, 2016</article-title>. <source><italic toggle="yes">CA</italic>: <italic toggle="yes">Cancer J Clin</italic></source>. <year>2016</year>;<volume>66</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">26742998</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Lustberg</surname><given-names>MB</given-names></name>, <name><surname>Ramaswamy</surname><given-names>B</given-names></name>. <article-title>Epigenetic Therapy in Breast Cancer</article-title>. <source><italic toggle="yes">Curr Breast Cancer Rep</italic></source>. <year>2011</year>;<volume>3</volume>(<issue>1</issue>):<fpage>34</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1007/s12609-010-0034-0</pub-id>
<?supplied-pmid 23097683?><pub-id pub-id-type="pmid">23097683</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Widschwendter</surname><given-names>M</given-names></name>, <name><surname>Jones</surname><given-names>PA</given-names></name>. <article-title>DNA methylation and breast carcinogenesis</article-title>. <source><italic toggle="yes">Oncogene</italic></source>. <year>2002</year>;<volume>21</volume>(<issue>35</issue>):<fpage>5462</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1205606</pub-id>
<?supplied-pmid 12154408?><pub-id pub-id-type="pmid">12154408</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Jovanovic</surname><given-names>J</given-names></name>, <name><surname>Rønneberg</surname><given-names>JA</given-names></name>, <name><surname>Tost</surname><given-names>J</given-names></name>, <name><surname>Kristensen</surname><given-names>V</given-names></name>. <article-title>The epigenetics of breast cancer</article-title>. <source><italic toggle="yes">Molecular Oncol</italic></source>. <year>2010</year>;<volume>4</volume>(<issue>3</issue>):<fpage>242</fpage>–<lpage>54</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Baylin</surname><given-names>SB</given-names></name>, <name><surname>Jones</surname><given-names>PA</given-names></name>. <article-title>A decade of exploring the cancer epigenome—biological and translational implications</article-title>. <source><italic toggle="yes">Nat Rev Cancer</italic></source>. <year>2011</year>;<volume>11</volume>(<issue>10</issue>):<fpage>726</fpage><pub-id pub-id-type="doi">10.1038/nrc3130</pub-id><?supplied-pmid 21941284?><pub-id pub-id-type="pmid">21941284</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>Y</given-names></name>, <name><surname>Nayak</surname><given-names>S</given-names></name>, <name><surname>Jankowitz</surname><given-names>R</given-names></name>, <name><surname>Davidson</surname><given-names>NE</given-names></name>, <name><surname>Oesterreich</surname><given-names>S</given-names></name>. <article-title>Epigenetics in breast cancer: what's new?</article-title><source><italic toggle="yes">Breast Cancer Res</italic></source>. <year>2011</year>;<volume>13</volume>(<issue>6</issue>):<fpage>225</fpage><pub-id pub-id-type="doi">10.1186/bcr2925</pub-id><?supplied-pmid 22078060?><pub-id pub-id-type="pmid">22078060</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Beach</surname><given-names>SR</given-names></name>, <name><surname>Dogan</surname><given-names>MV</given-names></name>, <name><surname>Lei</surname><given-names>MK</given-names></name>, <name><surname>Cutrona</surname><given-names>CE</given-names></name>, <name><surname>Gerrard</surname><given-names>M</given-names></name>, <name><surname>Gibbons</surname><given-names>FX</given-names></name>, <etal>et al</etal><article-title>Methylomic Aging as a Window onto the Influence of Lifestyle: Tobacco and Alcohol Use Alter the Rate of Biological Aging</article-title>. <source><italic toggle="yes">J Am Geriatr Soc</italic></source>. <year>2015</year>;<volume>63</volume>(<issue>12</issue>):<fpage>2519</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/jgs.13830</pub-id>
<?supplied-pmid 26566992?><pub-id pub-id-type="pmid">26566992</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Basse</surname><given-names>C</given-names></name>, <name><surname>Arock</surname><given-names>M</given-names></name>. <article-title>The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment</article-title>. <source><italic toggle="yes">Int J Cancer</italic></source>. <year>2015</year>;<volume>137</volume>(<issue>12</issue>):<fpage>2785</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.29347</pub-id>
<?supplied-pmid 25410431?><pub-id pub-id-type="pmid">25410431</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Gammon</surname><given-names>MD</given-names></name>, <name><surname>Hernandez-Vargas</surname><given-names>H</given-names></name>, <name><surname>Herceg</surname><given-names>Z</given-names></name>, <name><surname>Wetmur</surname><given-names>JG</given-names></name>, <name><surname>Teitelbaum</surname><given-names>SL</given-names></name>, <etal>et al</etal><article-title>DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study</article-title>. <source><italic toggle="yes">The FASEB Journal</italic></source>. <year>2012</year>;<volume>26</volume>(<issue>6</issue>):<fpage>2657</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1096/fj.11-197251</pub-id>
<?supplied-pmid 22371529?><pub-id pub-id-type="pmid">22371529</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Madigan</surname><given-names>MP</given-names></name>, <name><surname>Ziegler</surname><given-names>RG</given-names></name>, <name><surname>Benichou</surname><given-names>J</given-names></name>, <name><surname>Byrne</surname><given-names>C</given-names></name>, <name><surname>Hoover</surname><given-names>RN</given-names></name>. <article-title>Proportion of breast cancer cases in the United States explained by well-established risk factors</article-title>. <source><italic toggle="yes">JNCI</italic>: <italic toggle="yes">J Natl Cancer Inst</italic></source>. <year>1995</year>;<volume>87</volume>(<issue>22</issue>):<fpage>1681</fpage>–<lpage>5</lpage>. <?supplied-pmid 7473816?><pub-id pub-id-type="pmid">7473816</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><collab>Cancer CGoHFiB</collab>. <article-title>Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease</article-title>. <source><italic toggle="yes">The Lancet</italic></source>. <year>2002</year>;<volume>360</volume>(<issue>9328</issue>):<fpage>187</fpage>–<lpage>95</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Ban</surname><given-names>KA</given-names></name>, <name><surname>Godellas</surname><given-names>CV</given-names></name>. <article-title>Epidemiology of breast cancer</article-title>. <source><italic toggle="yes">Surg Oncol Clin N Amer</italic></source>. <year>2014</year>;<volume>23</volume>(<issue>3</issue>):<fpage>409</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">24882341</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Izadi</surname><given-names>P</given-names></name>, <name><surname>Noruzinia</surname><given-names>M</given-names></name>, <name><surname>Fereidooni</surname><given-names>F</given-names></name>, <name><surname>Mostakhdemine Hosseini</surname><given-names>Z</given-names></name>, <name><surname>Kamali</surname><given-names>F</given-names></name>. <article-title>Epigenetic marks in estrogen receptor alpha CpG island correlate with some reproductive risk factors in breast cancer</article-title>. <source><italic toggle="yes">Mol Biol Rep</italic></source>. <year>2014</year>;<volume>41</volume>(<issue>11</issue>):<fpage>7607</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-014-3650-3</pub-id>
<?supplied-pmid 25135164?><pub-id pub-id-type="pmid">25135164</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Demetriou</surname><given-names>CA</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Polidoro</surname><given-names>S</given-names></name>, <name><surname>Van Veldhoven</surname><given-names>K</given-names></name>, <name><surname>Cuenin</surname><given-names>C</given-names></name>, <name><surname>Campanella</surname><given-names>G</given-names></name>, <etal>et al</etal><article-title>Methylome analysis and epigenetic changes associated with menarcheal age</article-title>. <source><italic toggle="yes">PloS One</italic></source>. <year>2013</year>;<volume>8</volume>(<issue>11</issue>):<fpage>e79391</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0079391</pub-id><?supplied-pmid 24278132?><pub-id pub-id-type="pmid">24278132</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Metivier</surname><given-names>R</given-names></name>, <name><surname>Gallais</surname><given-names>R</given-names></name>, <name><surname>Tiffoche</surname><given-names>C</given-names></name>, <name><surname>Le Peron</surname><given-names>C</given-names></name>, <name><surname>Jurkowska</surname><given-names>RZ</given-names></name>, <name><surname>Carmouche</surname><given-names>RP</given-names></name>, <etal>et al</etal><article-title>Cyclical DNA methylation of a transcriptionally active promoter</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2008</year>;<volume>452</volume>(<issue>7183</issue>):<fpage>45</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1038/nature06544</pub-id>
<?supplied-pmid 18322525?><pub-id pub-id-type="pmid">18322525</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Weisenberger</surname><given-names>DJ</given-names></name>, <name><surname>Campan</surname><given-names>M</given-names></name>, <name><surname>Long</surname><given-names>TI</given-names></name>, <name><surname>Kim</surname><given-names>M</given-names></name>, <name><surname>Woods</surname><given-names>C</given-names></name>, <name><surname>Fiala</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Analysis of repetitive element DNA methylation by MethyLight</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source>. <year>2005</year>;<volume>33</volume>(<issue>21</issue>):<fpage>6823</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki987</pub-id>
<?supplied-pmid 16326863?><pub-id pub-id-type="pmid">16326863</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>AS</given-names></name>, <name><surname>Estécio</surname><given-names>MR</given-names></name>, <name><surname>Doshi</surname><given-names>K</given-names></name>, <name><surname>Kondo</surname><given-names>Y</given-names></name>, <name><surname>Tajara</surname><given-names>EH</given-names></name>, <name><surname>Issa</surname><given-names>JPJ</given-names></name>. <article-title>A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements</article-title>. <source><italic toggle="yes">Nucleic Acids Res</italic></source>. <year>2004</year>;<volume>32</volume>(<issue>3</issue>):<fpage>e38</fpage>–<lpage>e</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gnh032</pub-id>
<?supplied-pmid 14973332?><pub-id pub-id-type="pmid">14973332</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Gammon</surname><given-names>MD</given-names></name>, <name><surname>Neugut</surname><given-names>AI</given-names></name>, <name><surname>Santella</surname><given-names>RM</given-names></name>, <name><surname>Teitelbaum</surname><given-names>SL</given-names></name>, <name><surname>Britton</surname><given-names>JA</given-names></name>, <name><surname>Terry</surname><given-names>MB</given-names></name>, <etal>et al</etal><article-title>The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer</article-title>. <source><italic toggle="yes">Breast Cancer Res Treat</italic></source>. <year>2002</year>;<volume>74</volume>(<issue>3</issue>):<fpage>235</fpage>–<lpage>54</lpage>. <?supplied-pmid 12206514?><pub-id pub-id-type="pmid">12206514</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Shantakumar</surname><given-names>S</given-names></name>, <name><surname>Terry</surname><given-names>MB</given-names></name>, <name><surname>Teitelbaum</surname><given-names>SL</given-names></name>, <name><surname>Britton</surname><given-names>JA</given-names></name>, <name><surname>Millikan</surname><given-names>RC</given-names></name>, <name><surname>Moorman</surname><given-names>PG</given-names></name>, <etal>et al</etal><article-title>Reproductive factors and breast cancer risk among older women</article-title>. <source><italic toggle="yes">Breast Cancer Res Treat</italic></source>. <year>2007</year>;<volume>102</volume>(<issue>3</issue>):<fpage>365</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1007/s10549-006-9343-4</pub-id>
<?supplied-pmid 17033925?><pub-id pub-id-type="pmid">17033925</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Terry</surname><given-names>MB</given-names></name>, <name><surname>Zhang</surname><given-names>FF</given-names></name>, <name><surname>Kabat</surname><given-names>G</given-names></name>, <name><surname>Britton</surname><given-names>JA</given-names></name>, <name><surname>Teitelbaum</surname><given-names>SL</given-names></name>, <name><surname>Neugut</surname><given-names>AI</given-names></name>, <etal>et al</etal><article-title>Lifetime alcohol intake and breast cancer risk</article-title>. <source><italic toggle="yes">Annal Epidemiol</italic></source>. <year>2006</year>;<volume>16</volume>(<issue>3</issue>):<fpage>230</fpage>–<lpage>40</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Shantakumar</surname><given-names>S</given-names></name>, <name><surname>Terry</surname><given-names>MB</given-names></name>, <name><surname>Paykin</surname><given-names>A</given-names></name>, <name><surname>Teitelbaum</surname><given-names>SL</given-names></name>, <name><surname>Britton</surname><given-names>JA</given-names></name>, <name><surname>Moorman</surname><given-names>PG</given-names></name>, <etal>et al</etal><article-title>Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source>. <year>2007</year>;<volume>165</volume>(<issue>10</issue>):<fpage>1187</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwm006</pub-id>
<?supplied-pmid 17337757?><pub-id pub-id-type="pmid">17337757</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Eng</surname><given-names>SM</given-names></name>, <name><surname>Gammon</surname><given-names>MD</given-names></name>, <name><surname>Terry</surname><given-names>MB</given-names></name>, <name><surname>Kushi</surname><given-names>LH</given-names></name>, <name><surname>Teitelbaum</surname><given-names>SL</given-names></name>, <name><surname>Britton</surname><given-names>JA</given-names></name>, <etal>et al</etal><article-title>Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source>. <year>2005</year>;<volume>162</volume>(<issue>3</issue>):<fpage>229</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwi195</pub-id>
<?supplied-pmid 15987723?><pub-id pub-id-type="pmid">15987723</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>McCullough</surname><given-names>LE</given-names></name>, <name><surname>Eng</surname><given-names>SM</given-names></name>, <name><surname>Bradshaw</surname><given-names>PT</given-names></name>, <name><surname>Cleveland</surname><given-names>RJ</given-names></name>, <name><surname>Teitelbaum</surname><given-names>SL</given-names></name>, <name><surname>Neugut</surname><given-names>AI</given-names></name>, <etal>et al</etal><article-title>Fat or fit: the joint effects of physical activity, weight gain, and body size on breast cancer risk</article-title>. <source><italic toggle="yes">Cancer</italic></source>. <year>2012</year>;<volume>118</volume>(<issue>19</issue>):<fpage>4860</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.27433</pub-id>
<?supplied-pmid 22733561?><pub-id pub-id-type="pmid">22733561</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>McClain</surname><given-names>KM</given-names></name>, <name><surname>McCullough</surname><given-names>LE</given-names></name>, <name><surname>Bradshaw</surname><given-names>PT</given-names></name>, <name><surname>Shantakumar</surname><given-names>S</given-names></name>, <name><surname>Terry</surname><given-names>MB</given-names></name>, <name><surname>Neugut</surname><given-names>AI</given-names></name>, <etal>et al</etal><article-title>Age-Specific Indicators of a Healthy Lifestyle and Postmenopausal Breast Cancer</article-title>. <source><italic toggle="yes">J Women's Health</italic></source>. <year>2017</year>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Gammon</surname><given-names>MD</given-names></name>, <name><surname>Santella</surname><given-names>RM</given-names></name>, <name><surname>Neugut</surname><given-names>AI</given-names></name>, <name><surname>Eng</surname><given-names>SM</given-names></name>, <name><surname>Teitelbaum</surname><given-names>SL</given-names></name>, <name><surname>Paykin</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts</article-title>. <source><italic toggle="yes">Cancer Epidemiol Prev Biomarkers</italic></source>. <year>2002</year>;<volume>11</volume>(<issue>8</issue>):<fpage>677</fpage>–<lpage>85</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Bjornsson</surname><given-names>HT</given-names></name>, <name><surname>Sigurdsson</surname><given-names>MI</given-names></name>, <name><surname>Fallin</surname><given-names>MD</given-names></name>, <name><surname>Irizarry</surname><given-names>RA</given-names></name>, <name><surname>Aspelund</surname><given-names>T</given-names></name>, <name><surname>Cui</surname><given-names>H</given-names></name>, <etal>et al</etal><article-title>Intra-individual change over time in DNA methylation with familial clustering</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2008</year>;<volume>299</volume>(<issue>24</issue>):<fpage>2877</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1001/jama.299.24.2877</pub-id>
<?supplied-pmid 18577732?><pub-id pub-id-type="pmid">18577732</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>McShane</surname><given-names>LM</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Sauerbrei</surname><given-names>W</given-names></name>, <name><surname>Taube</surname><given-names>SE</given-names></name>, <name><surname>Gion</surname><given-names>M</given-names></name>, <name><surname>Clark</surname><given-names>GM</given-names></name>. <article-title>Reporting recommendations for tumor marker prognostic studies</article-title>. <source><italic toggle="yes">J Clinl Oncol</italic></source>. <year>2005</year>;<volume>23</volume>(<issue>36</issue>):<fpage>9067</fpage>–<lpage>72</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Eads</surname><given-names>CA</given-names></name>, <name><surname>Danenberg</surname><given-names>KD</given-names></name>, <name><surname>Kawakami</surname><given-names>K</given-names></name>, <name><surname>Saltz</surname><given-names>LB</given-names></name>, <name><surname>Danenberg</surname><given-names>PV</given-names></name>, <name><surname>Laird</surname><given-names>PW</given-names></name>. <article-title>CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression</article-title>. <source><italic toggle="yes">Cancer Res</italic></source>. <year>1999</year>;<volume>59</volume>(<issue>10</issue>):<fpage>2302</fpage>–<lpage>6</lpage>. <?supplied-pmid 10344733?><pub-id pub-id-type="pmid">10344733</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Belli</surname><given-names>RF</given-names></name>. <article-title>The structure of autobiographical memory and the event history calendar: Potential improvements in the quality of retrospective reports in surveys</article-title>. <source><italic toggle="yes">Memory</italic></source>. <year>1998</year>;<volume>6</volume>(<issue>4</issue>):<fpage>383</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1080/741942610</pub-id>
<?supplied-pmid 9829098?><pub-id pub-id-type="pmid">9829098</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Brennan</surname><given-names>K</given-names></name>, <name><surname>Flanagan</surname><given-names>JM</given-names></name>. <article-title>Is there a link between genome-wide hypomethylation in blood and cancer risk?</article-title><source><italic toggle="yes">Cancer Prev Res</italic></source>. <year>2012</year>;<volume>5</volume>(<issue>12</issue>):<fpage>1345</fpage>–<lpage>57</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Knol</surname><given-names>MJ</given-names></name>, <name><surname>VanderWeele</surname><given-names>TJ</given-names></name>. <article-title>Recommendations for presenting analyses of effect modification and interaction</article-title>. <source><italic toggle="yes">Int J Epidemiol</italic></source>. <year>2012</year>;<volume>41</volume>(<issue>2</issue>):<fpage>514</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyr218</pub-id>
<?supplied-pmid 22253321?><pub-id pub-id-type="pmid">22253321</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Assmann</surname><given-names>SF</given-names></name>, <name><surname>Hosmer</surname><given-names>DW</given-names></name>, <name><surname>Lemeshow</surname><given-names>S</given-names></name>, <name><surname>Mundt</surname><given-names>KA</given-names></name>. <article-title>Confidence intervals for measures of interaction</article-title>. <source><italic toggle="yes">Epidemiology</italic></source>. <year>1996</year>;<volume>7</volume>(<issue>3</issue>):<fpage>286</fpage>–<lpage>90</lpage>. <?supplied-pmid 8728443?><pub-id pub-id-type="pmid">8728443</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref033">
                <label>33</label>
                <mixed-citation publication-type="book"><name><surname>David</surname><given-names>K</given-names></name>, <name><surname>Mitchel</surname><given-names>K</given-names></name>. <source>Logistic regression: A self learning text</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer–Verlag Inc</publisher-name>; <year>1994</year>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Taby</surname><given-names>R</given-names></name>, <name><surname>Issa</surname><given-names>JP</given-names></name>. <article-title>Cancer epigenetics</article-title>. <source><italic toggle="yes">CA</italic>: <italic toggle="yes">Cancer J Clin</italic></source>. <year>2010</year>;<volume>60</volume>(<issue>6</issue>):<fpage>376</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">20959400</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>JY</given-names></name>, <name><surname>James</surname><given-names>SR</given-names></name>, <name><surname>Link</surname><given-names>PA</given-names></name>, <name><surname>McCann</surname><given-names>SE</given-names></name>, <name><surname>Hong</surname><given-names>CC</given-names></name>, <name><surname>Davis</surname><given-names>W</given-names></name>, <etal>et al</etal><article-title>Association between global DNA hypomethylation in leukocytes and risk of breast cancer</article-title>. <source><italic toggle="yes">Carcinogenesis</italic></source>. <year>2009</year>;<volume>30</volume>(<issue>11</issue>):<fpage>1889</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgp143</pub-id>
<?supplied-pmid 19584139?><pub-id pub-id-type="pmid">19584139</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Terry</surname><given-names>MB</given-names></name>, <name><surname>Delgado-Cruzata</surname><given-names>L</given-names></name>, <name><surname>Vin-Raviv</surname><given-names>N</given-names></name>, <name><surname>Wu</surname><given-names>HC</given-names></name>, <name><surname>Santella</surname><given-names>RM</given-names></name>. <article-title>DNA methylation in white blood cells: association with risk factors in epidemiologic studies</article-title>. <source><italic toggle="yes">Epigenetics</italic></source>. <year>2011</year>;<volume>6</volume>(<issue>7</issue>):<fpage>828</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.4161/epi.6.7.16500</pub-id>
<?supplied-pmid 21636973?><pub-id pub-id-type="pmid">21636973</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Costello</surname><given-names>JF</given-names></name>, <name><surname>Plass</surname><given-names>C</given-names></name>. <article-title>Methylation matters</article-title>. <source><italic toggle="yes">J Med Genet</italic></source>. <year>2001</year>;<volume>38</volume>(<issue>5</issue>):<fpage>285</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.38.5.285</pub-id>
<?supplied-pmid 11333864?><pub-id pub-id-type="pmid">11333864</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Kuchiba</surname><given-names>A</given-names></name>, <name><surname>Iwasaki</surname><given-names>M</given-names></name>, <name><surname>Ono</surname><given-names>H</given-names></name>, <name><surname>Kasuga</surname><given-names>Y</given-names></name>, <name><surname>Yokoyama</surname><given-names>S</given-names></name>, <name><surname>Onuma</surname><given-names>H</given-names></name>, <etal>et al</etal><article-title>Global methylation levels in peripheral blood leukocyte DNA by LUMA and breast cancer: a case-control study in Japanese women</article-title>. <source><italic toggle="yes">Brit J Cancer</italic></source>. <year>2014</year>;<volume>110</volume>(<issue>11</issue>):<fpage>2765</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.2014.223</pub-id>
<?supplied-pmid 24786600?><pub-id pub-id-type="pmid">24786600</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Delgado-Cruzata</surname><given-names>L</given-names></name>, <name><surname>Wu</surname><given-names>HC</given-names></name>, <name><surname>Perrin</surname><given-names>M</given-names></name>, <name><surname>Liao</surname><given-names>Y</given-names></name>, <name><surname>Kappil</surname><given-names>MA</given-names></name>, <name><surname>Ferris</surname><given-names>JS</given-names></name>, <etal>et al</etal><article-title>Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry</article-title>. <source><italic toggle="yes">Epigenetics</italic></source>. <year>2012</year>;<volume>7</volume>(<issue>8</issue>):<fpage>868</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.4161/epi.20830</pub-id>
<?supplied-pmid 22705975?><pub-id pub-id-type="pmid">22705975</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>ZZ</given-names></name>, <name><surname>Hou</surname><given-names>L</given-names></name>, <name><surname>Bollati</surname><given-names>V</given-names></name>, <name><surname>Tarantini</surname><given-names>L</given-names></name>, <name><surname>Marinelli</surname><given-names>B</given-names></name>, <name><surname>Cantone</surname><given-names>L</given-names></name>, <etal>et al</etal><article-title>Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis</article-title>. <source><italic toggle="yes">Int J Epidemiol</italic></source>. <year>2012</year>;<volume>41</volume>(<issue>1</issue>):<fpage>126</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyq154</pub-id>
<?supplied-pmid 20846947?><pub-id pub-id-type="pmid">20846947</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Langevin</surname><given-names>SM</given-names></name>, <name><surname>Pinney</surname><given-names>SM</given-names></name>, <name><surname>Leung</surname><given-names>Y-K</given-names></name>, <name><surname>Ho</surname><given-names>S-M</given-names></name>. <article-title>Does epigenetic drift contribute to age-related increases in breast cancer risk?</article-title><source><italic toggle="yes">Epigenomics</italic></source>. <year>2014</year>;<volume>6</volume>(<issue>4</issue>):<fpage>367</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.2217/epi.14.28</pub-id>
<?supplied-pmid 25333845?><pub-id pub-id-type="pmid">25333845</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Fraga</surname><given-names>MF</given-names></name>, <name><surname>Esteller</surname><given-names>M</given-names></name>. <article-title>Epigenetics and aging: the targets and the marks</article-title>. <source><italic toggle="yes">Trends in Genetics</italic></source>. <year>2007</year>;<volume>23</volume>(<issue>8</issue>):<fpage>413</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2007.05.008</pub-id>
<?supplied-pmid 17559965?><pub-id pub-id-type="pmid">17559965</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Brennan</surname><given-names>K</given-names></name>, <name><surname>Flanagan</surname><given-names>JM</given-names></name>. <article-title>Is there a link between genome-wide hypomethylation in blood and cancer risk?</article-title><source><italic toggle="yes">Cancer Prev Res</italic></source>. <year>2012</year>;<volume>5</volume>(<issue>12</issue>):<fpage>1345</fpage>–<lpage>57</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Simons</surname><given-names>RL</given-names></name>, <name><surname>Lei</surname><given-names>MK</given-names></name>, <name><surname>Beach</surname><given-names>SR</given-names></name>, <name><surname>Philibert</surname><given-names>RA</given-names></name>, <name><surname>Cutrona</surname><given-names>CE</given-names></name>, <name><surname>Gibbons</surname><given-names>FX</given-names></name>, <etal>et al</etal><article-title>Economic hardship and biological weathering: the epigenetics of aging in a US sample of black women</article-title>. <source><italic toggle="yes">Soc Sci Med</italic></source>. <year>2016</year>;<volume>150</volume>:<fpage>192</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.socscimed.2015.12.001</pub-id>
<?supplied-pmid 26765221?><pub-id pub-id-type="pmid">26765221</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Caspi</surname><given-names>A</given-names></name>, <name><surname>Moffitt</surname><given-names>TE</given-names></name>, <name><surname>Thornton</surname><given-names>A</given-names></name>, <name><surname>Freedman</surname><given-names>D</given-names></name>, <name><surname>Amell</surname><given-names>JW</given-names></name>, <name><surname>Harrington</surname><given-names>H</given-names></name>, <etal>et al</etal><article-title>The life history calendar: a research and clinical assessment method for collecting retrospective event-history data</article-title>. <source><italic toggle="yes">Int J Methods Psychiatr Res</italic></source>. <year>1996</year>.</mixed-citation>
              </ref>
              <ref id="pone.0210884.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>Z</given-names></name>, <name><surname>Bolick</surname><given-names>SC</given-names></name>, <name><surname>DeRoo</surname><given-names>LA</given-names></name>, <name><surname>Weinberg</surname><given-names>CR</given-names></name>, <name><surname>Sandler</surname><given-names>DP</given-names></name>, <name><surname>Taylor</surname><given-names>JA</given-names></name>. <article-title>Epigenome-wide association study of breast cancer using prospectively collected sister study samples</article-title>. <source>JNCI: <italic toggle="yes">J Natl Cancer Inst</italic></source>. <year>2013</year>;<volume>105</volume>(<issue>10</issue>):<fpage>694</fpage>–<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/djt045</pub-id>
<?supplied-pmid 23578854?><pub-id pub-id-type="pmid">23578854</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0210884.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>DeSantis</surname><given-names>C</given-names></name>, <name><surname>Ma</surname><given-names>J</given-names></name>, <name><surname>Bryan</surname><given-names>L</given-names></name>, <name><surname>Jemal</surname><given-names>A</given-names></name>. <article-title>Breast cancer statistics, 2013</article-title>. <source><italic toggle="yes">CA</italic>: <italic toggle="yes">Cancer J Clin</italic></source>. <year>2014</year>;<volume>64</volume>(<issue>1</issue>):<fpage>52</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">24114568</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
